top of page

Pioneering Genetic Therapies for Duchenne Muscular Dystrophy


At ART BioScience we are committed to the development of a new class of therapeutics based on messenger RNA (mRNA) for the treatment of Orphan diseases, primarily Duchenne Muscular Dystrophy


To be recognized as a leader in the discovery, development and commercialization of novel mRNA therapeutics by leveraging a deep understanding of Duchenne biology, specifically strengthening the musculoskeletal system. 


Genetic musculoskeletal system disorders

art bioscience.png

Treat Orphan Diseases,

Primarily Duchenne Muscular Dystrophy


Our leadership team has deep and diverse industry knowledge, a passion for science and innovation, and we consistently push the boundaries of scientific excellence and discovery in order to transform lives.


We are advancing innovative mRNA genetic therapeutics for Duchenne Molecular Dystrophy using our proprietary Nano Lipid Particles  delivery system

Blue Pathway
bottom of page